Press release
Parkinson's Disease Treatment Market Size, Key Players, Future Growth Opportunities by 2026
According to IMARC Group's latest report, titled "Parkinson's Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026", the global parkinson's disease treatment market is expected to grow at a CAGR of around 6% during 2021-2026. Parkinson's disease refers to a progressive nervous system disorder that affects movements in an individual. It is characterized by the degeneration of motor neurons in the brain that leads to the development of rigidity, tremors, motor impairment, depression and dementia. Healthcare professionals are widely utilizing medications, supportive therapies and surgical procedures to manage the symptoms of the disease in an efficient manner and offer comfort to the patient during a seizure. Some of the most commonly prescribed medications include dopamine agonists, anticholinergics and carbidopa-levodopa medicines.We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request for a PDF sample of this report: https://www.imarcgroup.com/parkinsons-disease-treatment-market/requestsample
Market Trends and Drivers:
The parkinson's disease treatment market is primarily driven by the steadily increasing number of patients suffering from Parkinson's disease on the global level. Along with this, a considerable rise in the geriatric population that is more prone to develop neurodegenerative ailments is expected to provide a thrust to the market growth. Moreover, continual developments in gene therapy, neurostimulation tools, and neural transplantation procedures are anticipated to create a positive outlook for the market. Some of the other factors contributing to the market growth include rising awareness regarding efficient treatment options and significant improvements in the healthcare infrastructure.
Parkinson's Disease Treatment Market Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the parkinson's disease treatment market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
AbbVie Inc.
Acadia Pharmaceuticals Inc.
Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
F. Hoffmann-La Roche AG
GlaxoSmithKline Plc
H. Lundbeck A/S
Merck & Co. Inc.
Mylan N.V.
Novartis AG
Orion Corporation
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries
Wockhardt Ltd.
Key Market Segmentation:
The report has segmented the global parkinson's disease treatment market on the basis of region, drug class, administration and distribution channel.
Breakup by Drug Class:
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO Inhibitors
COMT Inhibitors
Anticholinergics
Others
Breakup by Route of Administration:
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Breakup by Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2792&flag=C
Key Highlights of the Report:
Market Performance (2015-2020)
Market Outlook (2021-2026)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parkinson's Disease Treatment Market Size, Key Players, Future Growth Opportunities by 2026 here
News-ID: 2642374 • Views: โฆ
More Releases from IMARC Group

UAE Pharmaceutical Market Size Worth USD 8.02 Billion by 2033 | CAGR: 7.30%
๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐๐ซ๐ค๐๐ญ ๐ข๐ง ๐๐๐ ๐๐๐๐:
๐๐จ๐ฐ ๐๐ข๐ ๐ข๐ฌ ๐ญ๐ก๐ ๐๐๐ ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ?
The UAE pharmaceutical market size was valued at ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐. Looking forward, IMARC Group estimates the market to reach ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, exhibiting a CAGR of ๐.๐๐% from 2025-2033.
๐๐๐ซ๐ค๐๐ญ ๐๐ญ๐๐ญ๐ข๐ฌ๐ญ๐ข๐
๐๐๐ฌ๐ ๐๐๐๐ซ: 2024
๐๐ข๐ฌ๐ญ๐จ๐ซ๐ข๐๐๐ฅ ๐๐๐๐ซ๐ฌ: 2019-2024
๐
๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ซ๐ฌ: 2025-2033
๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐ข๐ง ๐๐๐๐: ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง
๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐ข๐ง ๐๐๐๐: ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐๐ญ๐ (๐๐๐๐) ๐๐๐๐-๐๐๐๐: ๐.๐๐%
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐
๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐โฆ

Tanzania Mobile Money Market Set to Reach USD 221.0 Billion by 2033, Growing at โฆ
๐๐๐ง๐ณ๐๐ง๐ข๐ ๐๐จ๐๐ข๐ฅ๐ ๐๐จ๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
๐๐๐ฌ๐ ๐๐๐๐ซ: 2024
๐๐ข๐ฌ๐ญ๐จ๐ซ๐ข๐๐๐ฅ ๐๐๐๐ซ๐ฌ: 2019-2024
๐
๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐ซ๐ฌ: 2025-2033
๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐ข๐ง ๐๐๐๐: ๐๐๐ ๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง
๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐ข๐ง ๐๐๐๐: ๐๐๐ ๐๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐๐ญ๐ (๐๐๐๐) ๐๐๐๐-๐๐๐๐: ๐๐%
According to IMARC Group's report titled "๐๐๐ง๐ณ๐๐ง๐ข๐ ๐๐จ๐๐ข๐ฅ๐ ๐๐จ๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ง๐ ๐
๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐-๐๐๐๐," the market reached ๐๐๐ ๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐. Looking forward, IMARC Group expects the market to reach ๐๐๐ ๐๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, exhibiting a growth rate (CAGR) of ๐๐%โฆ

South East Asia Chiral Chemicals Market Size, Share | Trends & Forecast Report 2 โฆ
๐๐จ๐ฎ๐ญ๐ก ๐๐๐ฌ๐ญ ๐๐ฌ๐ข๐ ๐๐ก๐ข๐ซ๐๐ฅ ๐๐ก๐๐ฆ๐ข๐๐๐ฅ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐ข๐ง ๐๐๐๐:
๐๐จ๐ฐ ๐๐ข๐ ๐ข๐ฌ ๐ญ๐ก๐ ๐๐ก๐ข๐ซ๐๐ฅ ๐๐ก๐๐ฆ๐ข๐๐๐ฅ๐ฌ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ?
South East Asia chiral chemicals market size is projected to exhibit a growth rate (๐๐๐๐) ๐จ๐ ๐๐.๐๐% ๐๐ฎ๐ซ๐ข๐ง๐ ๐๐๐๐-๐๐๐๐.
The South East Asia chiral chemicals market is driven by increasing demand across the pharmaceutical, agrochemical, and fine chemical industries, along with advancements in chemical synthesis technologies.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ :https://www.imarcgroup.com/south-east-asia-chiral-chemicals-market/requestsample
๐๐จ๐ฎ๐ญ๐ก ๐๐๐ฌ๐ญ ๐๐ฌ๐ข๐ ๐๐ก๐ข๐ซ๐๐ฅ ๐๐ก๐๐ฆ๐ข๐๐๐ฅ๐ฌ ๐๐๐ซ๐ค๐๐ญโฆ

Qatar Smartphone Market Size, Share | Trends & Analysis 2025-2033
๐๐๐ญ๐๐ซ ๐๐ฆ๐๐ซ๐ญ๐ฉ๐ก๐จ๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐ข๐ง ๐๐๐๐:
๐๐จ๐ฐ ๐๐ข๐ ๐ข๐ฌ ๐ญ๐ก๐ ๐๐ฆ๐๐ซ๐ญ๐ฉ๐ก๐จ๐ง๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ?
The Qatar smartphone market size reached ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง in 2024. Looking forward, IMARC Group expects the market to reach ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง by 2033, exhibiting a growth rate (๐๐๐๐) ๐จ๐ ๐.๐๐% ๐๐ฎ๐ซ๐ข๐ง๐ ๐๐๐๐-๐๐๐๐.
๐๐๐ญ๐๐ซ ๐๐ฆ๐๐ซ๐ญ๐ฉ๐ก๐จ๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.imarcgroup.com/qatar-smartphone-market/requestsample
๐๐๐ญ๐๐ซ ๐๐ฆ๐๐ซ๐ญ๐ฉ๐ก๐จ๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
The Qatar smartphone market is expanding rapidly, owing to the high mobile penetration rates as wellโฆ
More Releases for Parkinson
QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency.
The firm recognised that to continue delivering high quality services to its clients it needed to provideโฆ
Wolff Parkinson White syndrome Market found Future opportunities of 2023
The Analysis presents the study of Global Wolff Parkinson White syndrome Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold
Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Globalโฆ
PARKINSON RESEARCH FOUNDATION Announces Director of Patient Programs, Services a โฆ
The Parkinson Research Foundation is pleased to announce that Marilyn Tait has joined the foundation as the Director of Patient Programs, Services and Advocacy. Tait, is a graduate of Thomas Jefferson University School of Nursing in Philadelphia, Pennsylvania. Tait has forty years experience in healthcare marketing and program development. After specializing in oncology for 30 years, Tait embarked on her new career at a time in her life whenโฆ
PARKINSON RESEARCH FOUNDATIONโS (PRF) WESTERN CARIBBEAN FOURTH EDUCATIONAL CRU โฆ
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field.
After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRFโs ventured to the Western Caribbean on its mostโฆ
PARKINSON RESEARCH FOUNDATION (PRF) Develops New Patient Outreach Program
One of the principal missions of the Parkinson Research Foundation (PRF) that distinguishes it from other Parkinson organizations is PRFโs focus on patient education; specifically education that enables Parkinson patients and their caregivers to live fuller and more comfortable lives with Parkinson's disease.
The Foundationโs educational events, including educational cruises, gather leading Parkinson experts, therapists and nutritionists from across the country to offer life-changing tools and knowledge for individuals affectedโฆ
Parkinson`s Disease:New Hope Educational Conference
PARKINSONโS DISEASE: NEW HOPE EDUCATIONAL CONFERENCE
Become knowledgeable about the advancements in surgery
The Parkinson Research Foundation is proud to announce that Dr. James Schumacher will be speaking about advances in surgery at our fourth annual New Hope for Parkinsonโs conference on November 1st in Boca Raton. Dr. Schumacher is an internationally known expert in the field of neurosurgical treatment of Parkinsonโs disease and movement disorders. He has an extensive background andโฆ